ADEBRELIMAB

Clinical trials for ADEBRELIMAB explained in plain language.

Never miss a new study

Get alerted when new ADEBRELIMAB trials appear

Sign up with your email to follow new studies for ADEBRELIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cocktail aims to turn inoperable stomach cancer into a surgical target

Disease control Recruiting now

This study tests whether a combination of four drugs (adebrelimab, apatinib, oxaliplatin, and tigio) can shrink advanced stomach or gastroesophageal junction cancer enough to allow surgical removal. About 49 adults with cancer that cannot currently be removed will receive up to 8…

Matched conditions: ADEBRELIMAB

Phase: PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control

Last updated May 14, 2026 12:03 UTC

ADEBRELIMAB

Get alerted when new ADEBRELIMAB trials appear

New cocktail aims to turn inoperable stomach cancer into a surgical target